Mark Dunphy

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

29h-index3.4kcitations154works4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging Techniques and Applications(45), Radiopharmaceutical Chemistry and Applications(29), Radiomics and Machine Learning in Medical Imaging(28), Lung Cancer Treatments and Mutations(24), Head and Neck Cancer Studies(23)

Publications154 total

Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms
JCO Precision Oncology·2025Open Access
Prospective validation of a pretreatment 18F-FDG PET/CT and mean lung dose model for early radiation pneumonitis
Physics and Imaging in Radiation Oncology·2025Open Access
18F-BMS-986229 PET imaging of tumor PD-L1 expression in glioblastoma patients
EJNMMI Research·2025· 1 citedOpen Access
Prospective Validation of a Pretreatment 18F FDG PET CT plus Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Consolidation Immunotherapy
International Journal of Radiation Oncology*Biology*Physics·2025
Lesion Absorbed Dose–Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy
Journal of Nuclear Medicine·2025· 3 citedOpen Access
Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms
2025· 1 citedOpen Access
Landscape of functional DLL3 expression in gastroenteropancreatic neuroendocrine neoplasms (GEP NENs).
Journal of Clinical Oncology·2025· 1 cited
Imaging with [ <sup>89</sup> Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with neuroendocrine tumors of the prostate: A phase 1/2, first-in-human trial.
Journal of Clinical Oncology·2025
A Retrospective Observational Study of Complex Specialist Rehabilitation Needs in a Major Trauma Center
Archives of Physical Medicine and Rehabilitation·2025
Symptomatic Prostate-Specific Membrane Antigen PET–Positive Radionecrosis After Multimodality Brain Metastasis–Directed Treatment Including [<sup>177</sup>Lu]Lu-PSMA-617
Journal of Nuclear Medicine·2025· 1 cited
Supplementary Data from A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors
2024Open Access
Data from A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors
2024Open Access
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment <sup>18</sup> F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non–Small Cell Lung Cancer
Journal of Clinical Oncology·2024· 29 citedOpen Access
Epichaperome-targeted myocardial imaging by 124I-PU-H71 PET
Clinical and Translational Imaging·2024· 2 citedOpen Access
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
The Lancet Oncology·2024· 37 citedOpen Access
First-in-human imaging with [ <sup>89</sup> Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate
2024· 4 citedOpen Access
Epichaperome-targeted Myocardial Imaging by 124I-PU-H71 PET
Research Square (Research Square)·2023Open Access
Supplementary Data from Safety and Feasibility of PARP1/2 Imaging with &lt;sup&gt;18&lt;/sup&gt;F-PARPi in Patients with Head and Neck Cancer
2023Open Access
Data from Safety and Feasibility of PARP1/2 Imaging with &lt;sup&gt;18&lt;/sup&gt;F-PARPi in Patients with Head and Neck Cancer
2023Open Access
Supplementary Data from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Jason S. Lewis(11), Gabriela Chiosis(10), Pat Zanzonico(9), Serge K. Lyashchenko(9), Nagavarakishore Pillarsetty(9), Steven M. Larson(9), Tony Taldone(8), Shanu Modi(7), Eva Burnazi(7), Audrey Mauguen(7), Anna Rodina(6), Heiko Schöder(6), Milan Grkovski(6), John F. Gerecitano(5), Adriana Corben(5), Alexander Bolaender(5), James J. Harding(5), Wolfgang Weber(4), Tai Wang(4), Pengrong Yan(4)